GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (B5ELV3)

Analyse AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (B5ELV3) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B5ELV3
Type
protein
Length
414 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x3BB61284E47a075411d99C0E0F0AFdea58cF5CD6
Molecule
Serine hydroxymethyltransferase
UniProt
B5ELV3
Pockets
2 · best druggability 0.45

Structure

1 distinct chain · 49% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASerine hydroxymethyltransferaseprotein41449% helix, 14% strandB5ELV3

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11540.450.7637empty
21430.420.7519empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.